Koyfin Home > Directory > Health Care > Amedisys Inc > EBITDA

Amedisys Inc EBITDA Chart (AMED)

Amedisys Inc annual/quarterly EBITDA from 2010 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Amedisys Inc EBITDA for the quarter ending June 06, 2020 was $51m a 0.54% increase of 0m year over year
  • Amedisys Inc EBITDA for the last 12 months ending June 06, 2020 was $202m a 6.81% increase of 14m year over year
  • Amedisys Inc Annual EBITDA for 2019 was $197m a 14.67% increase of 29m from 2018
  • Amedisys Inc Annual EBITDA for 2018 was $168m a 23.83% increase of 40m from 2017
  • Amedisys Inc Annual EBITDA for 2017 was $128m a 36.51% increase of 47m from 2016
Other Income Statement Metrics:
  • Amedisys Inc Net Income for the quarter ending December 12, 2018 was $27m a 1.10% increase of 0m year over year
  • Amedisys Inc Total Revenue for the quarter ending December 12, 2018 was $434m a 8.08% increase of 35m year over year
View Chart On Koyfin

Quarterly AMED EBITDA Data

06/2020$51m
03/2020$50m
12/2019$49m
09/2019$51m
06/2019$50m
03/2019$47m
12/2018$40m
09/2018$43m
06/2018$46m
03/2018$40m

Annual AMED EBITDA Data

2019$197m
2018$168m
2017$128m
2016$81m
2015$88m
2014$66m
2013$45m
2012$93m
2011$150m
2010$256m